(Q33361649)

26 July 2017

title

Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy (English)

1 reference

26 July 2017

David C Smith

2

0 references

author name string

Joseph M Herman

1

1 reference

26 July 2017

James Montie

3

1 reference

26 July 2017

James A Hayman

4

1 reference

26 July 2017

Molly A Sullivan

5

1 reference

26 July 2017

Elizabeth Kent

6

1 reference

26 July 2017

Kent A Griffith

7

1 reference

26 July 2017

Peggy Esper

8

1 reference

26 July 2017

Howard M Sandler

9

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

26 July 2017

1 reference

26 July 2017

volume

64

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

69-73

1 reference

Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence?

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Overview of bladder cancer trials in the Radiation Therapy Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Organ preservation strategies in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Quality of life aspects of bladder cancer: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Bladder preservation by combined modality therapy for invasive bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Measuring patients' perceptions of the outcomes of treatment for early prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Quality of life in patients with bladder carcinoma after cystectomy: first results of a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

Assessment of QOL and survival for patients undergoing radical cystectomy or bladder preservation for invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.02.024

10.1016/J.UROLOGY.2004.02.024

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference